Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271)
Bodey, G.P.; Rodriguez, V.; Hart, J.; Freireich, E.J.
Cancer ChemoTherapy Reports 54(4): 255-262
1970
ISSN/ISBN: 0069-0112 PMID: 4946010 Document Number: 23195
Document emailed within 1 workday
Related Documents
Whitecar, J.P.; Bodey, G.P.; Freireich, E.J.; McCredie, K.B.; Hart, J.S. 1972: Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults Cancer ChemoTherapy Reports 56(4): 543-550Burns, C.P. 1975: Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia Cancer ChemoTherapy Reports 59(4): 757-760
Takemoto, Y.; Sampi, K.; Kuraishi, Y.; Okabe, K.; Tamura, K.; Mizoguchi, H.; Saito, H.; Masaoka, T.; Ogawa, M. 1999: A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. the KRN8602 Leukemia Study Group International Journal of Hematology 70(1): 20-25
Ramsay, N.K.; Coccia, P.F.; Krivit, W.; Bloomfield, C.D.; Nesbit, M.E. 1976: Vinblastine, procarbazine, and cytosine arabinoside in combination for reinduction of childhood acute myelocytic leukemia Cancer Treatment Reports 60(11): 1683-1685
Wang, Y.F.; Curtis, J.E.; Lipton, J.; Minkin, S.; McCulloch, E.A.; Lipton, M. 1991: Cytosine arabinoside (ara-C) and cis-dichlorodiammineplatinum Ii (cisplatin) alone and in combination: effects on acute myeloblastic leukemia blast cells in culture and in vivo Leukemia 5(6): 522-527
Ohshima, A.; Yoshida, K.; Sato, T.; Miyazaki, S.; Yanagisawa, M.; Nakayama, Y.; Takahashi, T.; Mamiya, S.; Fukusima, Y.; Miura, A.B. 1987: Intermediate- and high-dose cytosine arabinoside therapy in acute refractory leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(1): 192-195
Hoelzer, D.; Thiel, E.; Löffler, H.; Büchner, T.; Ganser, A.; Heil, G.; Kurrle, E.; Heimpel, H.; Koch, P.; Lipp, T. 1987: Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia Seminars in Oncology 14(2 Suppl 1: 92-97
Wiernik, P.H.; Schimpff, S.C.; Schiffer, C.A.; Lichtenfeld, J.L.; Aisner, J.; O'connell, M.J.; Fortner, C. 1976: Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia Cancer Treatment Reports 60(1): 41-53
Derulska, D.; Rokicka-Milewska, R. 1975: Cytosine arabinoside in the treatment of acute leukemia in children Pediatria Polska 50(6): 723-728
Hirschmann, W.D.; Kovacs, E.L.; Gerecke, D.; Kaulen, H.D.; Voigtmann, R.; Gross, R. 1975: Method of administration and inactivation of cytosine arabinoside in acute leukemia Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1114-1116
Lin, S.F.; Liu, H.W.; Chen, T.P. 1990: Chemotherapy for acute non-lymphocytic leukemia with low-dose cytosine arabinoside (Ara-C) Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 53(1): 45-50
Pedersen, G.; Stentoft, J.; Pedersen, J.O.; Jensen, M.K. 1994: Treatment of acute myeloid leukemia in the elderly with low-dose cytosine arabinoside Ugeskrift for Laeger 156(43): 6380-6384
Kansu, E.; Koc, Y.; Kars, A.; Alakavuklar, M.; Tekuzman, G.; Firat, D. 1989: Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report Journal of ChemoTherapy 1(4 Suppl): 1268-1270
Ezaki, K. 2000: Interferon-alpha and cytosine arabinoside therapy in chronic myeloid leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 279-284
Wakita, A.; Murase, T.; Uchida, T.; Fujiwara, Y.; Tanaka, M.; Ohkita, T. 1992: Mitoxantrone and conventional-dose cytosine arabinoside for relapsed and refractory acute leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(5): 653-657
Wysocki, M.; Nowaczyk-Michalak, A.; Pilecki, O.; Trybuś, L.; Balcar-Boroń, A. 1992: Jaundice following high--dose arabinoside cytosine in a child with acute myelogenous leukemia Acta Haematologica Polonica 23(3): 197-199
Gingrich, R.D.; Armitage, J.O.; Burns, C.P. 1978: Treatment of adult acute lymphoblastic leukemia with cytosine arabinoside, vincristine, and prednisone Cancer Treatment Reports 62(9): 1389-1391
Kinoshita, N.; Tochigi, H.; Yanagawa, M.; Yamakawa, K.; Sakurai, M.; Hioki, T.; Kawamura, J. 1990: Clinical study of intravesical instillation therapy of superficial bladder tumor--combination therapy of mitomycin C, adriamycin, peplomycin and cytosine arabinoside Hinyokika Kiyo. Acta Urologica Japonica 36(3): 257-263
Kobayashi, S.; Sakai, H.; Tomiazwa, T.; Koiso, H.; Kim, K.; Ueki, K.; Tamura, J.; Yano, S.; Naruse, T.; Karasawa, M. 1999: Successful low-dose cytosine arabinoside treatment in a patient with acute leukemia from idiopathic myelofibrosis Journal of Medicine 30(1-2): 101-109
Ota, K.; Kurita, S.; Nishimura, M.; Ogawa, M.; Kamei, Y.; Imai, K.; Ariyoshi, Y.; Kataoka, K.; Murakami, M.; Oyama, A.; Hoshino, A.; Amo, H.; Kato, T. 1972: Combination therapy with mitomycin C (NSC-26980), 5-fluorouracil (NSC-19893), and cytosine arabinoside (NSC-63878) for advanced cancer in man Cancer ChemoTherapy Reports 56(3): 373-385